Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by ichibanichiban9

Order by:

BLUSD	RE:Still a solid buy at this price Something tells me a buyout is going to happen sooner rather than later... July 14, 2019
BLUSD	RE:Question for Mr ichibanichiban9 Merck had an Investor day event yesterday showcasing their products and... June 21, 2019
BLUSD	RE:Did anyone see Bellus news today? (I did not see any.) Check Merck Gefapixant, P2X3. June 20, 2019
BLUSD	Alzheon Ph 3 update Alzheon news that I guess everyone missed today. Bellus also has new... July 25, 2016
BLUSD	RE:RE:Tramiprosate in 3rd phase trial Shareholders of Bellus may want to follow Alzheon. The association between... July 15, 2016
BLUSD	RE:Does anyone know how much $$$$ they have in the bank At the end of Q1 they had $9M cash. Burn rate is only about $1m/quarter... July 12, 2016
BLUSD	RE:RE:ANSWER OS BELLUS... The alzehimer drug trials of Tramiprosate is what you are referring to is now... July 9, 2016
BLUSD	KIACTA sale According to Bellus news release and corporate presentation in Feb 2016, sale... March 26, 2016
BLUSD	Alzheon association with Bellus Without question Kiacta Ph 3 results and its potential commercization is the... March 13, 2016
BLUSD	Alzheon Alzheon is certainly on the radar in the world of Life Science Startups in... March 12, 2016
BLUSD	Confirmation of efficacy in Prior Tramiprosate Phase 3 This could be part of the reason for the run up in Bellus stock the past week... March 11, 2016
BLUSD	The value of scarcity found in rare disease drugs Orphan drug M & A in the U.S. for Ph 3 drug... Reuters) - Alexion... May 7, 2015
BLUSD	Putting an Alzheimer's drug potential in perspective Since Bellus receives almost no coverage, below is what analysts in a Barron&... April 8, 2015
BLUSD	Alzheon may offer Bellus Shareholder upside on Alzheimer's http://www.bizjournals.com/boston/blog/bioflash/2015/04/alzheons-ceo-says-he... April 8, 2015

Featured News Links

Silver Range Resources: A hidden gem in the mining industry

Featured Company

Kane Biotech Inc. V.KNE

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and ... view more »